Krishna Institute of Medical Sciences (KIMS) is a Hyderabad-based company that operates multi-specialty hospitals in Telangana and Andhra Pradesh.
The company's Rs 21.4 bn initial public offering (IPO) will hit the street on 16 June, alongside Dodla Dairy.
The price band of the offer has been fixed between Rs 815 and Rs 825 per equity share.
Axis Capital, Kotak Mahindra Capital, Credit Suisse Securities, and IIFL Securities have been appointed as merchant bankers to advise the company on the IPO.
Link Intime India will be the registrar to Krishna Institute of Medical Sciences issue.
| Issue Type | Book Built Issue IPO |
| Face Value | Rs 10 per equity share |
| IPO Price | Rs 815 to Rs 825 per equity share |
| Market Lot | 1 lot - 18 shares |
| Issue Size | Rs 21.4 bn |
| Fresh Issue | Rs 2 bn |
| Offer for Sale | Rs 19.4 bn |
| Basis of Allotment Date | Wednesday, June 23, 2021 |
| IPO Listing Date | Monday, June 28, 2021 |
Currently, the promoters hold 46.8% stake in the company, post issue the shareholding will come down to 38.8%.
The company's existing investors, US equity giant General Atlantic and the promoters, will offer 21.3 m shares totaling to Rs 19.4 bn.
Dr. Bhaskara Rao Bollineni, Rajyasri Bollineni, Dr. Abhinay Bollineni, Adwik Bollineni, and Bollineni Ramanaiah Memorial Hospitals Private Limited are the company promoters.
--- Advertisement ---
The 20 Greatest Outlier Stocks
There's a very tiny minority of listed companies that have the potential to be the greatest wealth creators for Indian investors.
Having studied the Indian stock markets for 20 years now, our top analyst and Co-Head of Research, Tanushree Banerjee has zeroed in on the ultimate list of 20 such stocks.
On June 21 at 5pm, Tanushree will be revealing the full details on these stocks for Indian investors.
You Register your FREE spot for her Forever Stocks event with this link.
------------------------------
Up to 75% (Rs 15.9 bn) portion of the net offer has been reserved for qualified institutional buyers (QIBs), 15% (Rs 3.2 bn) for non-institutional buyers (NIBs) and 10% (Rs 2.1 bn) for retail investors.
While equity shares worth Rs 200 m have been kept reserved for employees.
A discount of Rs 40 per share will be given to the eligible employees bidding in the employee reservation portion.
The IPO proceeds worth Rs 2 bn raised via fresh issue will go to the company.
Of this, it intends to repay Rs 1.5 bn worth borrowing.
The remaining Rs 500 m will go towards general corporate purposes, which can include capital expenditure, partnerships, among other things.
Incorporated in 1973, Krishna Institute of Medical Sciences is one of the largest healthcare groups in Andhra Pradesh and Telangana.
KIMS provides multi-disciplinary healthcare services with a key focus on primary, secondary, and tertiary care in tier 2-3 cities.
The company offers a comprehensive range of healthcare services including oncology, cardiac sciences, neurosciences, gastric sciences, orthopedics, renal sciences, organ transplantation, and mother & child care.
As of 31 March 2021, it operates through 9 multi-specialty hospitals under the brand name of 'KIMS Hospitals' with an aggregate bed capacity of 3,064 including over 2,500 operational beds.
FREE: Tanushree Banerjee's Controversial Event on Forever Stocks
KIMS wants to ride the bull run in India's equity markets to expand its operations to adjacent areas like Karnataka, Odisha, Tamil Nadu, and even central India.
Among these, Bengaluru and Chennai could be the next big markets for KIMS.
Apart from this, the liquidity boost could help KIMS expand its bed capacity and healthcare equipment to augment its operations.
The company has posted growth in its top and bottom lines for the last three fiscals.
For the last three financial years, the company has (on a consolidated basis) posted an average earnings per share (EPS) of Rs 17.4.
The issue is priced at a P/BV (price to book value) of 7.2 based on its net asset value (NAV) of Rs 115.4 as of 31 March 2021.
| (Rs m) | FY18 | FY19 | FY20 | Dec-20 |
|---|---|---|---|---|
| Revenues | 6,636.7 | 9,180.1 | 11,226.5 | 9,714.0 |
| Revenue Growth (%) | 38.3% | 22.3% | ||
| Expenses | 7,213.9 | 9,389.1 | 9,882.0 | 7,793.8 |
| Profit Before Tax (PBT) | -204.5 | -150.4 | 1,405.3 | 1,980.0 |
| Net Profit | -461.9 | -485.9 | 1,150.7 | 1,468.6 |
As per offer documents, KIMS has not paid any dividend in the last three fiscals but will follow a prudent dividend policy based on its financial performance, future prospects and the procedure framed for the same.
For more details, check out Krishna Institute of Medical Sciences Red Herring Prospectus.
--- Advertisement ---
A Financial Crisis is Imminent: Here's the Plan to Survive it
The financial world is about to witness a major crisis....
A crisis so big that it could send shock waves around the world and create a global economic disruption.
This is no prophecy. And definitely not an overstatement.
You see, the crisis I'm talking about has been in the making for many years now...And the COVID-19 pandemic has only pushed the dates forward.
But, luckily, there's a way to protect your wealth and potentially make big gains in the long run.
My colleague, who also happens to be India's #1 trader, just revealed me to this conventional yet attractive investment...
This could not only protect your wealth during the crisis but also has the potential to generate double - triple digit gains in the long run.
Here's the asset I'm talking about...
------------------------------
The hospital's two branches, namely KIMS Kondapur and KIMS Secunderabad - both located in Hyderabad, contribute nearly two-thirds to the total revenue of the company.
A high concentration of revenue could hamper the company's prospects if it cannot expand and diversify in a meaningful manner.
Despite a surge in revenue and profit, KIMS says that the Covid-19 pandemic had an adverse impact on its operations.
The company says that in March 2020 and more so in April 2020, it witnessed a substantial decline in in-patient and out-patient volumes.
When compared to February 2020, its inpatient volumes fell by more than half in April 2020.
It also notes that some patients were reluctant to visit hospitals due to a perceived notion of increased risk of infection.
Heightened risk of its doctors, nurses and other healthcare workers, and a resulting increase in costs to ensure their safety also remains another area of concern for the company.
The peer group companies listed in India are Apollo Hospitals Enterprise, Fortis Healthcare, Narayana Hrudayalaya, and Max Healthcare Institute.
| Company | Revenues | Net Profit | Return on Net Worth (%) |
|---|---|---|---|
| Apollo Hospitals | 112.5 | 4.3 | 13.6% |
| Fortis Healthcare | 46.3 | 0.8 | 0.9% |
| Narayana Hrudayalaya | 31.3 | 1.2 | 10.5% |
| Max Healthcare | 18.8 | 1.0 | 1.9% |
| Krishna Institute | 11.2 | 1.2 | 16.8% |
The grey market, where investors seek the first cue on public issues, is sufficiently enthused too.
The unofficial market for trading in unlisted shares is signaling good response for most of the current IPO issues.
As of 15 June 2021, KIMS Hospital is commanding a grey market premium of Rs 150-160, signaling a 18-20% upside over the issue price.
According to analysts, the company's business model is attractive, but high pricing is a concern.
There is not much buzz about the issue. However, they expect it to be a positive surprise for investors.
The excitement surrounding the slew of IPOs in the coming months is huge.
As many as four companies are coming out with their IPOs this week.
These include Shyam Metalics, Sona Comstar, Dodla Dairy, and Krishna Institute of Medical Sciences.
Investors are already euphoric on loss making companies such as Zomato and Paytm.
Smallcap analyst at Equitymaster, Richa Agarwal, recently shares her views on the much-hyped Paytm IPO.
Here's what she wrote...
You can read the entire editorial here: Paytm IPO: Will it Deliver Profits?
If you are investing in an IPO, weigh in all the positive and negative factors affecting the company.
Take a close look at the company's financials and valuations. It would give you a clear picture of what's brewing.
Happy Investing!
Disclaimer: This article is for information purposes only. It is not a stock recommendation and should not be treated as such. Learn more about our recommendation services here...
FDC share price is trading up by 5% and its current market price is Rs 402. The BSE HEALTHCARE is down by 0.0%. The top gainers in the BSE HEALTHCARE Index is FDC (up 5.1%). The top losers are WOCKHARDT (down 0.1%) and LUPIN (down 0.1%).
The stock jumped 3.6% in intraday trade to hit its 52-week high.
Laurus Labs trades higher for the eight straight day, soars 73% in 3 months.
Here's a rundown on the latest quarterly results of Jubilant Pharmova.
Recent developments in digital healthcare and revised targets by brokerages send Lupin shares flying.
More Views on NewsAs an investor, you must have endeavoured to find a suitable opportunity for investing in IPOs. But do you know what is an IP...
This is why I'm bullish on the hotel and hospitality sector.
The best unlock investments you can make in the market.
Jun 9, 2021Investing in the best stocks could result in wealth compounding on a massive scale.
Jun 2, 2021Get ready to profit from a massive stimulus that you've never seen before.
More
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!